Generate Biomedicines has filed for an IPO on the Nasdaq, seeking to raise upwards of $100 million for its AI-powered drug discovery operations. Incubated by Flagship Pioneering, Generate applies AI ...
Abstract: Recent advances in AI research are boosting the relevance of realtime neural networks in automation technology. To facilitate the deployment of trained neural networks for realtime ...
The Scaffold Generator library is designed to make molecular scaffold-related functionalities available in applications and workflows based on the Chemistry Development Kit (CDK). Building mainly upon ...
Abstract: Recently, Fuzzing is one of the most successful techniques to expose bugs in software. For testing large programs or large codebase with many features and entry-points, the creation of ...
Clinical-stage antibody company Generate:Biomedicines is the latest biotech to mull going public as momentum for IPOs continues to build. The Flagship-founded biotech has yet to set out how many ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Generate:Biomedicines raised ...
Writing compelling, SEO-optimized meta descriptions is time-consuming and requires expertise. Metatag AI Generate eliminates this burden by intelligently analyzing your content and generating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results